What question did this study set out to answer?

To assess the therapeutic outcomes, safety, and clinical efficacy of transcatheter embolization for pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.

November 1, 1998Acta Radiologica

Embolotherapy for Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome)

View Full Paper

Ask AI

Bookmark

To assess the therapeutic outcomes, safety, and clinical efficacy of transcatheter embolization for pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
Conducted an interventional case series in Fyn, Denmark, involving 12 patients with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).
Treated 20 pulmonary arteriovenous malformations via transcatheter embolotherapy using 12 detachable silicone balloons and 26 steel coils.
Evaluated procedural success through post-treatment arterial oxygen tension (PaO2) measurements and contrast echocardiography to quantify right-to-left shunting.
Achieved 100% complete occlusion across all 20 pulmonary arteriovenous malformations, leading to a significant increase in PaO2 and a significant reduction in right-to-left shunt.
All 12 patients demonstrated improved functional capacity following transcatheter intervention.
Complications were rare, limited to one case of severe pleurisy and one transient post-procedure temperature elevation without other symptomatic events.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Clinical study demonstrates complete malformation occlusion and improved arterial oxygenation in hereditary hemorrhagic telangiectasia, indicating embolotherapy is a safe definitive intervention.

Cite This Study

Andersen et al. (1998) studied this question.

synapsesocial.com/papers/6aa38557240321efda554d2d https://doi.org/10.3109/02841859809175505

View Full Paper

Ask AI

Bookmark

Implication

Clinical study demonstrates complete malformation occlusion and improved arterial oxygenation in hereditary hemorrhagic telangiectasia, indicating embolotherapy is a safe definitive intervention.

Embolotherapy for Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome)

Key Points

Discussion

Implication

Cite This Study

Embolotherapy for Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome)

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider